564 related articles for article (PubMed ID: 19650784)
1. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
Fernandez A; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784
[TBL] [Abstract][Full Text] [Related]
2. Clinical and endocrine aspects of pituitary tumors.
Zargar AH; Laway BA; Masoodi SR; Salahuddin M; Ganie MA; Bhat MH; Wani AI; Bashir MI
Saudi Med J; 2004 Oct; 25(10):1428-32. PubMed ID: 15494816
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of pituitary adenomas.
Karavitaki N
Ann Endocrinol (Paris); 2012 Apr; 73(2):79-80. PubMed ID: 22520147
[TBL] [Abstract][Full Text] [Related]
4. Incidence of pituitary adenomas in Northern Finland in 1992-2007.
Raappana A; Koivukangas J; Ebeling T; Pirilä T
J Clin Endocrinol Metab; 2010 Sep; 95(9):4268-75. PubMed ID: 20534753
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
[TBL] [Abstract][Full Text] [Related]
6. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.
Tjörnstrand A; Gunnarsson K; Evert M; Holmberg E; Ragnarsson O; Rosén T; Filipsson Nyström H
Eur J Endocrinol; 2014 Oct; 171(4):519-26. PubMed ID: 25084775
[TBL] [Abstract][Full Text] [Related]
7. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of pituitary adenoma: results of the first Swiss study].
Fontana E; Gaillard R
Rev Med Suisse; 2009 Oct; 5(223):2172-4. PubMed ID: 19968031
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
Daly AF; Rixhon M; Adam C; Dempegioti A; Tichomirowa MA; Beckers A
J Clin Endocrinol Metab; 2006 Dec; 91(12):4769-75. PubMed ID: 16968795
[TBL] [Abstract][Full Text] [Related]
12. Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom.
Bujawansa S; Thondam SK; Steele C; Cuthbertson DJ; Gilkes CE; Noonan C; Bleaney CW; Macfarlane IA; Javadpour M; Daousi C
Clin Endocrinol (Oxf); 2014 Mar; 80(3):419-24. PubMed ID: 23909507
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
[TBL] [Abstract][Full Text] [Related]
15. Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls.
van der Klaauw AA; Biermasz NR; Pereira AM; van Kralingen KW; Dekkers OM; Rabe KF; Smit JW; Romijn JA
Clin Endocrinol (Oxf); 2008 Nov; 69(5):769-74. PubMed ID: 18435832
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of neurogenins and NeuroD1 in human pituitary tumours.
Fratticci A; Grieco FA; Spilioti C; Giangaspero F; Ventura L; Esposito V; Piccirilli M; Santoro A; Gulino A; Cantore G; Alesse E; Jaffrain-Rea ML
J Endocrinol; 2007 Sep; 194(3):475-84. PubMed ID: 17761887
[TBL] [Abstract][Full Text] [Related]
17. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.
van der Klaauw AA; Kars M; Biermasz NR; Roelfsema F; Dekkers OM; Corssmit EP; van Aken MO; Havekes B; Pereira AM; Pijl H; Smit JW; Romijn JA
Clin Endocrinol (Oxf); 2008 Nov; 69(5):775-84. PubMed ID: 18462264
[TBL] [Abstract][Full Text] [Related]
18. [Pituitary apoplexy: analysis of endocrine function in 17 cases].
Fernández Real JM; Villabona CM; Montaña E; Acebes JJ; Ricart W; Sahún M; Gómez JM; Soler J
Med Clin (Barc); 1991 Apr; 96(14):521-4. PubMed ID: 2051802
[TBL] [Abstract][Full Text] [Related]
19. Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal.
Tortosa F; Webb SM
Neurologia; 2016 Mar; 31(2):97-105. PubMed ID: 26300499
[TBL] [Abstract][Full Text] [Related]
20. [The diagnosis and therapy of subclinical pituitary adenoma apoplexy].
Li JL; Yu CJ
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):879-81. PubMed ID: 16083609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
